Our identification of VRK2-mediated SLC7A11 trafficking suggests a potential immune evasion mechanism, as SLC7A11-high tumors often display T cell exclusion phenotypes [37], warranting future investigation into whether VRK2 expression could predict therapeutic response to combined ferroptosis inducers and immune checkpoint inhibitors
Int J Mol Sci, 21(12):4232
Dosage & Administration ['Wet face', 'Apply small amount, lather and massage for 30 seconds', 'Rinse thoroughly', 'Use twice daily', 'Follow with sunscreen during day'] Side Effects ['Mild stinging', 'Skin dryness', 'Sun sensitivity'] Contraindications & Precautions ['Hypersensitivity to any component', 'Active rosacea or eczema', 'Open wounds', 'Children under 12'] Storage Store below 30C
Oral Tranexamic Acid is an anti-fibrinolytic agent
Virtual Consultation Online consultation through our website
10.1111/j.1365-3059.2010.02340.x 82 KovtunY.ChiuW